Coliseum Capital Management, LLC has been buying UTI.

1. The buy: Coliseum Capital Management, LLC, a Director, bought 708,107 shares of UTI on 1-2 December 2025 — $17,130,752 at $24.19 a share.
2. The entry above is not that price. A Form 4 discloses what they paid on their own trade date, which was before anyone else could see it. Ours is the opening price on the first session after this became public.
3. Filed: 3 December 2025.

Risk: this is an INSTITUTION, not an executive. A fund or trust with a board seat or a 10% stake is building a position, and it may be averaging in, hedged elsewhere, or acting on a mandate that has nothing to do with a view on the next quarter. That is a different signal from a chief executive buying their own stock, which is why it posts here rather than under Big Insider Buys. An automated tracker of public SEC filings, not a recommendation.